Core Insights - Novo Nordisk has decided to cut its cell therapy division, which was focused on finding a cure for type 1 diabetes [1] Company Actions - The decision to cut the cell therapy division indicates a strategic shift for Novo Nordisk, as it moves away from this specific area of research [1]

Group 1 - Johnson & Johnson is in discussions to acquire Protagonist Therapeutics, indicating a potential strategic move in the biopharmaceutical sector [1]

Core Viewpoint - Equinor has abandoned its plans to reduce greenhouse gas emissions by connecting offshore platforms to Norway's onshore power grid due to rising costs [1] Group 1 - The decision to scrap the emissions reduction plan was communicated to the government by Equinor [1] - The primary reason for this decision is the significant increase in costs associated with the project [1]

Core Insights - Applied Digital's shares increased by 26% following the announcement of first-quarter revenue that exceeded analysts' expectations, driven by the growing adoption of artificial intelligence applications [1] Group 1: Company Performance - The company reported first-quarter revenue that surpassed analysts' estimates, indicating strong financial performance [1] - The surge in share price reflects positive market sentiment towards the company's growth prospects in the AI sector [1] Group 2: Industry Trends - The rising adoption of artificial intelligence applications is a key factor contributing to the company's revenue growth, highlighting a broader trend in the data center service industry [1]

Group 1 - Eni and YPF have finalized an engineering agreement for a liquefied natural gas project in Vaca Muerta [1] - The announcement was made during a presentation on Friday [1] - This collaboration highlights the ongoing investment in LNG projects in Argentina [1]

Tesla has priced the new version of its best-selling standard Model Y SUV at 421,996 Norwegian crowns ($41,714) in Norway, the electric vehicle maker's website showed on Friday. ...

Group 1 - Wall Street is focusing on U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as potential beneficiaries following Pfizer's agreement with the Trump administration to reduce drug prices [1]

President Donald Trump will announce a U.S. drug pricing deal in an announcement at 5 p.m. in the White House on Friday, CBS News reporter Jennifer Jacobs said in a post on X, citing people familiar with the matter. ...

Toronto-listed Gold Reserve said on Friday it has filed motions to disqualify a court officer and the judge overseeing an auction of shares in the parent of Venezuela-owned Citgo Petroleum, as well as... ...

Core Insights - The latest U.S. sanctions on Iranian petroleum exports significantly impact Sinopec, a major Chinese refining company, by targeting a terminal that handles 20% of its crude oil imports [1] Company Impact - Sinopec is affected by the sanctions as they specifically target a terminal crucial for its operations, which processes a substantial portion of its crude oil imports [1] Industry Implications - The sanctions represent a broader strategy by the U.S. to limit Iranian oil exports, which could lead to increased volatility in global oil markets and affect refining companies reliant on Iranian crude [1]